KINETA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KINETA INC and buy or sell other stocks, ETFs, and their options commission-free!About KANT
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
CEOShawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees5
Employees5
HeadquartersMercer Island, Washington
HeadquartersMercer Island, Washington
Founded2008
Founded2008
Employees5
Employees5
KANT Key Statistics
Market cap4.55M
Market cap4.55M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume15.46K
Average volume15.46K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.15
52 Week high$1.15
52 Week low$0.1806
52 Week low$0.1806
Stock Snapshot
KINETA INC(KANT) stock is priced at $0.34, giving the company a market capitalization of 4.55M. It carries a P/E multiple of -0.50.
On 2025-12-12, KINETA INC(KANT) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 15.46K.
Over the past 52 weeks, KINETA INC(KANT) stock has traded between a high of $1.15 and a low of $0.18.
Over the past 52 weeks, KINETA INC(KANT) stock has traded between a high of $1.15 and a low of $0.18.
People also own
Based on the portfolios of people who own KANT. This list is generated using Robinhood data, and it’s not a recommendation.